[Clinical pharmacokinetics of pyromecaine. Prolonged intravenous infusion and the relation between its antiarrhythmic effect and its concentration].
V K
VK
Piotrovskiĭ
S V
SV
Blagodatskikh
V I
VI
Metelitsa
V K
VK
Smirnov
V A
VA
Gorshkov
D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000097:blood*; D005117:Cardiac Complexes, Premature / Q000097:blood / Q000188:drug therapy; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D007700:Kinetics; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D011759:Pyrrolidines / Q000008:administration & dosage / Q000097:blood*; D013997:Time Factors
D000889:Anti-Arrhythmia Agents; D011759:Pyrrolidines; C000661:bumecain
Klinicheskaia farmakokinetika piromekaina. Dlitel'naia vnutrivennaia infuziia i sviaz' mezhdu antiaritmicheskim éffektom i kontsentratsieĭ preparata.